ADMA BIOLOGICS INC - COMMON STOCK

ADMA Biologics Announces Addition to the Russell 2000® Index

21 июн 2022 07:00:01 Источник Nasdaq GlobeNewswire

ADMA Biologics Announces First Quarter 2022 Financial Results and Provides Business Update

11 май 2022 16:05:01 Источник Nasdaq GlobeNewswire

ADMA Biologics to Report First Quarter 2022 Financial Results on May 11, 2022

04 май 2022 07:00:01 Источник Nasdaq GlobeNewswire

ADMA Announces Live Poster Presentation and Symposium on Real-World Experience with ASCENIV™ at CIS 2022

01 апр 2022 07:00:00 Источник Nasdaq GlobeNewswire

ADMA Biologics Announces FDA Approval of Extended Shelf Life for ASCENIV™ & BIVIGAM® from 24 to 36 Months

25 мар 2022 07:00:00 Источник Nasdaq GlobeNewswire

ADMA Biologics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update, Including $175M Debt Refinance with Hayfin Capital Management

24 мар 2022 16:05:00 Источник Nasdaq GlobeNewswire

ADMA Biologics to Report Fourth Quarter and Full Year 2021 Financial Results on March 24, 2022

21 мар 2022 07:00:00 Источник Nasdaq GlobeNewswire

ADMA BioCenters Receives FDA Approval for its Fifth Plasma Collection Center, Located in Conyers, GA

07 мар 2022 16:05:01 Источник Nasdaq GlobeNewswire

ADMA Biologics Announces Record Preliminary Fourth Quarter and Full Year 2021 Revenues and Provides 2022 Business Update

19 янв 2022 07:00:00 Источник Nasdaq GlobeNewswire

ADMA BioCenters Receives FDA Approval for its Fourth Plasma Collection Center Located in Goose Creek, SC

18 янв 2022 07:00:01 Источник Nasdaq GlobeNewswire

ADMA Biologics Adopts Limited Duration Stockholder Rights Plan

21 дек 2021 07:00:00 Источник Nasdaq GlobeNewswire

ADMA Biologics Provides Update on Global Intellectual Property Portfolio

09 дек 2021 07:00:00 Источник Nasdaq GlobeNewswire

ADMA Biologics Senior Vice President of Plasma Services Cyndi Tolman Elected to PPTA Source Board of Directors

17 ноя 2021 07:00:01 Источник Nasdaq GlobeNewswire

ADMA Biologics Advances Plasma Collection Center Expansion Plans with Opening of New Facility in Myrtle Beach, SC

16 ноя 2021 07:00:01 Источник Nasdaq GlobeNewswire

ADMA Biologics Reports Record Third Quarter 2021 Financial Results and Highlights Recent Progress and Accomplishments

10 ноя 2021 16:01:01 Источник Nasdaq GlobeNewswire

ADMA Biologics to Report Third Quarter 2021 Financial Results on November 10, 2021

03 ноя 2021 07:00:01 Источник Nasdaq GlobeNewswire

ADMA Biologics Announces Closing of $57.5 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

25 окт 2021 16:01:00 Источник Nasdaq GlobeNewswire

ADMA Biologics Announces Data Presented at the 2021 ISIRV-WHO Conference

22 окт 2021 07:00:00 Источник Nasdaq GlobeNewswire

ADMA Biologics Announces Pricing of Public Offering for $50 Million of Common Stock

21 окт 2021 09:00:11 Источник Nasdaq GlobeNewswire

ADMA Biologics Announces Proposed Public Offering of Common Stock

20 окт 2021 16:01:00 Источник Nasdaq GlobeNewswire